159 related articles for article (PubMed ID: 31423718)
1. Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.
Huang X
J Thromb Haemost; 2019 Oct; 17(10):1655-1660. PubMed ID: 31423718
[TBL] [Abstract][Full Text] [Related]
2. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
Huang X; Swanson R; Kroh HK; Bock PE
J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
[TBL] [Abstract][Full Text] [Related]
3. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.
Girard TJ; Lasky NM; Grunz K; Broze GJ
J Thromb Haemost; 2019 Jan; 17(1):149-156. PubMed ID: 30451376
[TBL] [Abstract][Full Text] [Related]
4. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.
Huang X; Dementiev A; Olson ST; Gettins PG
J Biol Chem; 2010 Jun; 285(26):20399-409. PubMed ID: 20427285
[TBL] [Abstract][Full Text] [Related]
5. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).
Huang X; Liu B; Wei Y; Beyea R; Yan H; Olson ST
J Biol Chem; 2017 Sep; 292(35):14625-14635. PubMed ID: 28717005
[TBL] [Abstract][Full Text] [Related]
6. Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.
Huang X; Zhou J; Zhou A; Olson ST
J Biol Chem; 2015 Apr; 290(15):9906-18. PubMed ID: 25713144
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.
Huang X; Yan Y; Tu Y; Gatti J; Broze GJ; Zhou A; Olson ST
Blood; 2012 Aug; 120(8):1726-33. PubMed ID: 22786881
[TBL] [Abstract][Full Text] [Related]
8. Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.
Huang X; Swanson R; Olson ST
J Biol Chem; 2022 Jun; 298(6):102022. PubMed ID: 35551912
[TBL] [Abstract][Full Text] [Related]
9. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.
Rezaie AR; Bae JS; Manithody C; Qureshi SH; Yang L
J Biol Chem; 2008 Jul; 283(29):19922-6. PubMed ID: 18502758
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the protein Z-dependent protease inhibitor.
Han X; Fiehler R; Broze GJ
Blood; 2000 Nov; 96(9):3049-55. PubMed ID: 11049983
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
Huang X; Swanson R; Broze GJ; Olson ST
J Biol Chem; 2008 Oct; 283(44):29770-83. PubMed ID: 18768472
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.
Qureshi SH; Lu Q; Manithody C; Yang L; Rezaie AR
Biochim Biophys Acta; 2014 Sep; 1844(9):1631-7. PubMed ID: 24960590
[TBL] [Abstract][Full Text] [Related]
13. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
Rezaie AR; Manithody C; Yang L
J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
[TBL] [Abstract][Full Text] [Related]
14. Effect of variations in the conserved residues E371 and S359 on the structural dynamics of protein Z dependent protease inhibitor (ZPI): a molecular dynamic simulation study.
Chellam Gayathri S; Gupta S; Suresh A; Senapati S; Sengupta T
J Biomol Struct Dyn; 2022 Sep; 40(14):6405-6414. PubMed ID: 33554754
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.
Wei Z; Yan Y; Carrell RW; Zhou A
Blood; 2009 Oct; 114(17):3662-7. PubMed ID: 19528533
[TBL] [Abstract][Full Text] [Related]
16. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor.
Tabatabai A; Fiehler R; Broze GJ
Thromb Haemost; 2001 Apr; 85(4):655-60. PubMed ID: 11341501
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
[TBL] [Abstract][Full Text] [Related]
18. Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells.
Sierko E; Wojtukiewicz MZ; Zimnoch L; Tokajuk P; Ostrowska-Cichocka K; Kisiel W
Thromb Res; 2012 Apr; 129(4):e112-8. PubMed ID: 22424030
[TBL] [Abstract][Full Text] [Related]
19. Plasma concentration of protein Z and protein Z-dependent protease inhibitor in patients with haemophilia A.
Bolkun L; Galar M; Piszcz J; Lemancewicz D; Kloczko J
Thromb Res; 2013 Mar; 131(3):e110-3. PubMed ID: 23269381
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory properties of the P1 Tyr variant of antithrombin.
Yang L; Manithody C; Qureshi SH; Rezaie AR
Biochemistry; 2010 Mar; 49(12):2680-6. PubMed ID: 20184328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
